The role of natural killer cells in protection of mice against death and corneal scarring following ocular HSV-1 infection

Antiviral Research

Volumn 45, Issue 1, 2000, Pages 33-45

  Ghiasi, Homayon ^a,b   Cai, Steve ^a   Perng, Guey Chuen ^a   Nesburn, Anthony B ^a,b   Wechsler, Steven L ^a,b  

^a Ophthalmology Research   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Corneal scarring; HSV 1; NK depleted mice

Indexed keywords

ANTIBODY; GAMMA INTERFERON; GANGLIOTETRAOSYLCERAMIDE; HERPES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CORNEA DISEASE; DEATH; HERPES SIMPLEX; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTECTION; SCAR FORMATION; SURVIVAL; VACCINATION;

ANIMALS; CORNEA; HERPESVIRUS 1, HUMAN; INTERFERON TYPE II; KERATITIS, HERPETIC; KILLER CELLS, NATURAL; MACROPHAGES; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; T-LYMPHOCYTES; VACCINATION;

HUMAN HERPESVIRUS 1;

EID: 0033958962     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(99)00075-3     Document Type: Article

References (68)

1. Arase H., Arase N., Saito T. Interferon gamma production by natural killer (NK) cells and NK1.1+ T cells upon NKR-P1 cross-linking. J. Exp. Med. 183:1996;2391-2396.
2. Bancroft G.J., Shellam G.R., Chalmer J.E. Genetic influences on the augmentation of natural killer (NK) cells during murine cytomegalovirus infection: correlation with patterns of resistance. J. Immunol. 126:1981;988-994.
3. Bendelac A. Mouse NK1+ T cells. Curr. Opin. Immunol. 7:1995;367-374.
4. Bendelac A., Rivera M.N., Park S.H., Roark J.H. Mouse CD1-specific NK1 T cells: development, specificity, and function. Annu. Rev. Immunol. 15:1997;535-562.
5. Berra A., Rodriguez A., Heiligenhaus A., Pazos B., Van Rooijen N., Foster C.S The role of macrophages in the pathogenesis of HSV-1 induced chorioretinitis in BALB/c mice. Invest. Ophthalmol. Vis. Sci. 35:1994;2990-2998.
6. Binder P.S. A review of the treatment of ocular herpes simplex infections in the neonate and immunocompromised host. Cornea. 3:1984;178-182.
7. Biron C.A. Activation and function of natural killer cell responses during viral infections. Curr. Opin. Immunol. 9:1997a;24-34.
8. Biron C.A. Natural killer cell regulation during viral infection. Biochem. Soc. Trans. 25:1997b;687-690.
9. Biron C.A., Byron K.S., Sullivan J.L. Severe herpesvirus infections in an adolescent without natural killer cells. New Engl. J. Med. 320:1989;1731-1735.
10. Bonina L., Nash A.A., Arena A., Leung K.N., Wildy P. T cell-macrophage interaction in arginase-mediated resistance to herpes simplex virus. Virus Res. 1:1984;501-505.
11. Bouley D.M., Kanangat S., Rouse B.T. The role of the innate immune system in the reconstituted SCID mouse model of herpetic stromal keratitis. Clin. Immunol. Immunopathol. 80:1996;23-30.
12. Bukowski J.F., Welsh R.M. The role of natural killer cells and interferon in resistance to acute infection of mice with herpes simplex virus type 1. J. Immunol. 136:1986;3481-3485.
13. Bukowski J.F., Woda B.A., Habu S., Okumura K., Welsh R.M. Natural killer cell depletion enhances virus synthesis and virus- induced hepatitis in vivo. J. Immunol. 131(3):1983;1531-1538.
14. Chmielarczyk W., Engler H., Ernst R., Opitz U., Kirchner H. Injection of anti-thy-1.2 serum breaks genetic resistance of mice against herpes simplex virus. J. Gen. Virol. 66:1985;1087-1094.
15. Clark E.A., Russell P.H., Egghart M., Horton M.A. Characteristics and genetic control of NK-cell-mediated cytotoxicity activated by naturally acquired infection in the mouse. Int. J. Cancer. 24:1979;688-699.
16. Dawson C.R. Ocular herpes simplex virus infections. Clin. Dermatol. 2:1984;56-66.
17. Dawson C.R., Togni B. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv. Ophthalmol. 21:1976;121-135.
18. + T lymphocytes. Invest. Ophthalmol. Vis. Sci. 33:1992;2165-2173.
19. Engler H., Zawatzky R., Goldbach A. et al. Experimental infection of inbred mice with herpes simplex virus. II: interferon production and activation of natural killer cells in the peritoneal exudate. J. Gen. Virol. 55:1981;25-30.
20. Ghiasi H., Bahri S., Nesburn A.B., Wechsler S.L. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest. Ophthalmol. Vis. Sci. 36:1995a;1352-1360.
21. Ghiasi H., Cai S., Nesburn A.B., Wechsler S.L. MHC-II but not MHC-I responses are required for vaccine-induced protection against ocular challenge with HSV-1. Curr. Eye Res. 16:1997a;1152-1158.
22. Ghiasi H., Kaiwar R., Nesburn A.B., Slanina S., Wechsler S.L. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gD, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J. Virol. 68:1994;2118-2126.
23. Ghiasi H., Roopenian D.C., Slanina S., Cai S., Nesburn A.B., Wechsler S.L. The importance of MHC-I and MHC-II responses in vaccine efficacy against lethal herpes simplex virus type 1 challenge. Immunology. 91:1997b;430-435.
24. Ghiasi H., Wechsler S.L., Kaiwar R., Nesburn A.B., Hofman F.M. Local expression of tumor necrosis factor alpha and interleukin-2 correlates with protection against corneal scarring after ocular challenge of vaccinated mice with herpes simplex virus type 1. J. Virol. 69:1995b;334-340.
25. Ghiasi H., Cai S., Perng G-C., Nesburn A.B., Wechsler S.L. Perforin pathway is essential for protection of mice against lethal ocular HSV-1 challenge but not corneal scarring. Virus Res. 65:1999;97-101.
26. Glimcher L., Shen F.W., Cantor H. Identification of a cell-surface antigen selectively expressed on the natural killer cell. J. Exp. Med. 145:1977;1-9.
27. Gresser I., Tovey M.G., Maury C., Bandu M.T. Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II: studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses. J. Exp. Med. 144:1976;1316-1323.
28. Habu S., Akamatsu K., Tamaoki N., Okumura K. In vivo significance of NK cell on resistance against virus (HSV-1) infections in mice. J. Immunol. 133:1984;2743-2747.
29. Habu S., Fukui H., Shimamura K., Kasai M., Nagai Y., Okumura K., Tamaoki N. In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice. J. Immunol. 127:1981;34-38.
30. Hendricks R.L., Epstein R.J., Tumpey T. The effect of cellular immune tolerance to HSV-1 antigens on the immunopathology of HSV-1 keratitis. Invest. Ophthalmol. Vis. Sci. 30:1989;105-115.
31. Hendricks R.L., Janowicz M., Tumpey T.M. Critical role of corneal Langerhans cells in the CD4- but not CD8- mediated immunopathology in herpes simplex virus-1-infected mouse corneas. J. Immunol. 148:1992;2522-2529.
32. Hendricks R.L., Tumpey T.M. Contribution of virus and immune factors to herpes simplex virus type I- induced corneal pathology. Invest. Ophthalmol. Vis. Sci. 31:1990;1929-1939.
33. Herberman R.B., Ortaldo J.R. Natural killer cells: their roles in defenses against disease. Science. 214:1981;24-30.
34. Igietseme J.U., Streilein J.W., Miranda F., Feinerman S.J., Atherton S.S. Mechanisms of protection against herpes simplex virus type 1-induced retinal necrosis by in vitro-activated T lymphocytes. J. Virol. 65:1991;763-768.
35. Karlhofer F.M., Yokoyama W.M. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen: IL-2-activated NK cells possess additional specific stimulation pathways. J. Immunol. 146:1991;3662-3673.
36. Karupiah G., Blanden R.V., Ramshaw I.A. Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection. J. Exp. Med. 172:1990;1495-1503.
37. Kasai M., Iwamori M., Nagai Y., Okumura K., Tada T. A glycolipid on the surface of mouse natural killer cells. Eur. J. Immunol. 10:1980;175-180.
38. Kirchner H., Engler H., Schroder C.H., Zawatzky R., Storch E. Herpes simplex virus type 1-induced interferon production and activation of natural killer cells in mice. J. Gen. Virol. 64:1983;437-441.
39. Kohl S. The role of antibody in herpes simplex virus infection in humans. Curr. Top. Microbiol. Immunol. 179:1992;75-88.
40. Kohl S., Loo L.S., Drath D.B., Cox P. Interleukin-2 protects neonatal mice from lethal herpes simplex virus infection: a macrophage-mediated, gamma interferon-induced mechanism. J. Infect. Dis. 159:1989;239-247.
41. Koo G.C., Peppard J.R. Establishment of monoclonal anti-Nk-1.1 antibody. Hybridoma. 3:1984;301-303.
42. Kunder S.C., Wu L., Morahan P.S. Role of NK cells in immunomodulator-mediated resistance to herpesvirus infection. Antiviral Res. 21:1993;103-118.
43. Lausch R.N., Monteiro C., Kleinschrodt W.R., Oakes J.E. Superiority of antibody versus delayed hypersensitivity in clearance of HSV-1 from eye. Invest. Ophthalmol. Vis. Sci. 28:1987;565-570.
44. Lopez C., Ryshke R., Bennett M. Marrow-dependent cells depleted by 89Sr mediate genetic resistance to herpes simplex virus type 1 infection in mice. Infect. Immun. 28:1980;1028-1032.
45. Mosmann T.R., Coffman R.L. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:1989;145-173.
46. Nash A.A., Field H.J., Quartey-Papafio R. Cell-mediated immunity in herpes simplex virus-infected mice: induction, characterization and antiviral effects of delayed type hypersensitivity. J. Gen. Virol. 48:1980;351-357.
47. Newell C.K., Martin S., Sendele D., Mercadal C.M., Rouse B.T. Herpes simplex virus-induced stromal keratitis: role of T-lymphocyte subsets in immunopathology. J. Virol. 63:1989;769-775.
48. Paya C.V., Kenmotsu N., Schoon R.A., Leibson P.J. Tumor necrosis factor and lymphotoxin secretion by human natural killer cells leads to antiviral cytotoxicity. J. Immunol. 141:1988;1989-1995.
49. Rager-Zisman B., Quan P.C., Rosner M., Moller J.R., Bloom B.R. Role of NK cells in protection of mice against herpes simplex virus-1 infection. J. Immunol. 138:1987;884-888.
50. + T cell subsets and induces early resistance to Leishmania major in mice. J. Exp. Med. 178:1993;567-577.
51. Scott P., Trinchieri G. The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 7:1995;34-40.
52. Seaman W.E., Sleisenger M., Eriksson E., Koo G.C. Depletion of natural killer cells in mice by monoclonal antibody to NK- 1.1: reduction in host defense against malignancy without loss of cellular or humoral immunity. J. Immunol. 138:1987;4539-4544.
53. Shanley J.D. In vivo administration of monoclonal antibody to the NK 1.1 antigen of natural killer cells: effect on acute murine cytomegalovirus infection. J. Med. Virol. 30:1990;58-60.
54. Shellam G.R., Allan J.E., Papadimitriou J.M., Bancroft G.J. Increased susceptibility to cytomegalovirus infection in beige mutant mice. Proc. Natl. Acad. Sci. USA. 78:1981;5104-5108.
55. Smith A.L., Rose M.E., Wakelin D. The role of natural killer cells in resistance to coccidiosis: investigations in a murine model. Clin. Exp. Immunol. 97:1994;273-279.
56. Staats H.F., Oakes J.E., Lausch R.N. Anti-glycoprotein D monoclonal antibody protects against herpes simplex virus type 1-induced diseases in mice functionally depleted of selected T-cell subsets or asialo GM1+ cells. J. Virol. 65:1991;6008-6014.
57. Suttles J., Schwarting G.A., Stout R.D. Flow cytometric analysis reveals the presence of asialo GM1 on the surface membrane of alloimmune cytotoxic T lymphocytes. J. Immunol. 136:1986;1586-1591.
58. Tamesis R.R., Messmer E.M., Rice B.A., Dutt J.E., Foster C.S. The role of natural killer cells in the development of herpes simplex virus type 1 induced stromal keratitis in mice. Eye. 8:1994;298-306.
59. Thomas J., Gangappa S., Kanangat S., Rouse B.T. On the essential involvement of neutrophils in the immunopathologic disease: herpetic stromal keratitis. J. Immunol. 158:1997;1383-1391.
60. Trinchieri G. Biology of natural killer cells. Adv. Immunol. 47:1989;187-376.
61. Tumpey T.M., Chen S.H., Oakes J.E., Lausch R.N. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:1996;898-904.
62. Tutt M.M., Kuziel W.A., Hackett J. Jr, Bennett M., Tucker P.W., Kumar V. Murine natural killer cells do not express functional transcripts of the alpha-, beta-, or gamma-chain genes of the T cell receptor. J. Immunol. 137:1986;2998-3001.
63. Van Rooijen N., Sanders A. Liposome mediated depletion of macrophages: mechanism of action, preparation of liposomes and applications. J. Immunol. Meth. 174:1994;83-93.
64. Wang H.M., Dhue M.M., Stulting R.D., Kaplan H.J. Immunohistochemical evaluation of murine HSV-1 kertouveitis. Curr. Eye Res. 8:1989;37-46.
65. Welsh R.M., Dundon P.L., Eynon E.E., Brubaker J.O., Koo G.C., O'Donnell C.L. Demonstration of the antiviral role of natural killer cells in vivo with a natural killer cell-specific monoclonal antibody (NK 1.1). Nat. Immun. Cell. Growth Regul. 9:1990;112-120.
66. Wiltrout R.H., Santoni A., Peterson E.S. et al. Reactivity of anti-asialo GM1 serum with tumoricidal and non- tumoricidal mouse macrophages. J. Leukoc. Biol. 37:1985;597-614.
67. Yanez D.M., Manning D.D., Cooley A.J., Weidanz W.P., van der Heyde H.C. Participation of lymphocyte subpopulations in the pathogenesis of experimental murine cerebral malaria. J. Immunol. 157:1996;1620-1624.
68. +, NK1.1+ T cells that promptly produce interleukin 4. Proc. Natl. Acad. Sci. USA. 92:1995;11931-11934.